ABUS Financials
Arbutus Biopharma Corp - Financial statements & key metrics
Stock Price
$4.60
Market Cap
$929.56M
EPS
$-0.17
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$6.17M
Gross Profit
-
Operating Income
-
Net Income
$-69.92M
EPS (Diluted)
$-0.38
Balance Sheet Highlights
Total Assets
$131.71M
Total Liabilities
$34.34M
Shareholders Equity
-
Cash & Equivalents
$36.33M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-64.85M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-79.2%
Operating Margin
-7.3%
Net Margin
-2.4%
ROE
-0.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ABUS revenue?
ABUS's most recent quarterly revenue was $6.17M. Annual revenue can be calculated by summing the four most recent quarters.
Is ABUS profitable?
ABUS reported a loss of $69.92M in the most recent quarter. The net profit margin is -2.4%.
What is ABUS market cap?
ABUS has a market capitalization of $929.56M, making it a small-cap stock.
Does ABUS have debt?
View ABUS's balance sheet for debt information.
What is ABUS cash flow?
Cash flow data is available in the full financial statements.